Download PDF
Thromb Haemost 1996; 76(02): 139-142
DOI: 10.1055/s-0038-1650542
Original Article
Schattauer GmbH Stuttgart

New Mutations Causing the Premature Termination of Translation in the A Subunit Gene of Coagulation Factor XIII

Sasichai Kangsadalampai
1   The Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australia
,
Anne Farges-Berth
2   The Centre Hospitalier General, De Longjumeau, France
,
S Hande Çaglayan
3   The Department of Molecular Biology and Genetics, Bogaziçi University, Istanbul, Turkey
,
Philip G Board
1   The Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australia
› Author Affiliations
Further Information

Publication History

Received 06 February 1996

Accepted after resubmission 26 April 1996

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The amplification of factor XIIIA subunit gene exons and heteroduplex analysis has been used to identify two new mutations that cause severe factor XIII deficiency. One mutation in a family of French origin results from a 4 bp deletion and leads to a premature termination of translation. The other mutation occurred in a Turkish family and results from a C → T transition that inserts a premature translation stop signal at codon 400. Both mutations alter restriction enzyme sites and can be readily detected in amplified exon DNA for genetic counselling or prenatal diagnosis. The new mutations reflect the extensive molecular heterogeneity of factor XIII deficiency.

 

  • References

  • 1 Board PG, Losowsky MS, Miloszewski KJA. Factor XIII: Inherited and acquired deficiency. Blood Rev 1993; 7: 229-242
    CrossrefPubMedGoogle Scholar
  • 2 Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. J Biol Chem 1973; 248: 1395-1407
    PubMedGoogle Scholar
  • 3 Board PG. Genetic polymorphism of the A subunit of human coagulation factor XIII. Am J Hum Genet 1979; 31: 116-124
    PubMedGoogle Scholar
  • 4 Board PG. Genetic polymorphism of the B subunit of human coagulation factor XIII. Am J Hum Genet 1980; 32: 348-353
    PubMedGoogle Scholar
  • 5 Mary A, Achyuthan KE, Greenberg CS. β-chains prevent the proteolytic inactivation of the a-chains of plasma Factor XIII. Biochim Biophys Acta 1988; 966: 328-335
    CrossrefPubMedGoogle Scholar
  • 6 Bohn H. Comparative studies on the fibrin-stabilizing factors from human plasma, platelets and placentas. Ann New York Acad Sci 1972; 202: 256-272
    CrossrefPubMedGoogle Scholar
  • 7 Muszbek L, Adany R, Szegedi G, Polgar J, Kavai M. Factor XIII of blood coagulation in human monocytes. Thromb Res 1985; 37: 401-410
    CrossrefPubMedGoogle Scholar
  • 8 Adany R, Belkin A, Vasilevskaya T, Muszbek L. Identification of blood coagulation factor XIII in human peritoneal macrophages. Eur J Cell Biol 1985; 38: 171-173
    PubMedGoogle Scholar
  • 9 Board PG, Webb GC, McKee J, Ichinose A. Localization of the coagulation Factor XIIIA subunit gene (FI3A) to chromosome bands 6p24>p25. Cyto-gen Cell Genet 1986; 48: 25-27
    PubMedGoogle Scholar
  • 10 Webb GC, Coggan M, Ichinose A, Board PG. Localization of human coagulation Factor XIIIB subunit gene (FOB) to chromosome bands lq31-32.1 and restriction fragment polymorphism of the locus. Hum Genet 1989; 81: 157-160
    CrossrefPubMedGoogle Scholar
  • 11 Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilising factor deficiency. Thromb Diath Haemorr 1960; 5: 179-186
    PubMedGoogle Scholar
  • 12 Board P, Coggan M, Miloszewski K. Identification of a point mutation in Factor XIIIA subunit deficiency. Blood 1992; 80: 937-941
    PubMedGoogle Scholar
  • 13 Kamura T, Okamura T, Murakawa M, Tsuda H, Teshima T, Shibuya T, Harada M, Niho Y. Deficiency of coagulation Factor XIIIA subunit caused by the dinucleotide deletion at the 5’ end of exon III. J Clin Invest 1992; 90: 315-319
    CrossrefPubMedGoogle Scholar
  • 14 Standen GR, Bowen DJ. Factor XIII ABristol 1: detection of a nonsense mutation (Arg171→stop codon) in factor XIIIA subunit deficiency. Br J Haematol 1993; 85: 769-772
    CrossrefPubMedGoogle Scholar
  • 15 Mikkola H, Syrjala M, Rasi V, Vahtera E, Hamalainen E, Peltonen L, Palotie A. Deficiency in the A-subunit of coagulation Factor XIII: Two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-525
    PubMedGoogle Scholar
  • 16 Coggan M, Baker R, Miloszewski K, Woodfield G, Board P. Mutations causing coagulation Factor XIII subunit A deficiency: Characterization of the mutant proteins after expression in yeast. Blood 1995; 85: 2455-2460
    PubMedGoogle Scholar
  • 17 Vreken P, Niessen RWLM, Peters M, Schaap MCL, Zuithoffrijntjes JGM, Sturk A. A point mutation in an invariant splice acceptor site results in a decreased mRNA level in a patient with severe coagulation factor XIII subunit A deficiency. Throm Haemost 1995; 74: 584-589
    PubMedGoogle Scholar
  • 18 Aslam S, Poon MC, Yee VC, Bowen DJ, Standen GR. Factor XIIIA Calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit. Br J Haematol 1995; 91: 452-457
    CrossrefPubMedGoogle Scholar
  • 19 Anwar R, Stewart AD, Miloszewski KJA, Losowsky MS, Markham AF. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 1995; 91: 728-735
    CrossrefPubMedGoogle Scholar
  • 20 White MB, Carvalho M, Derse D, O’Brien SJ, Dean M. Detecting single base substitutions as heteroduplex polymorphisms. Genomics 1992; 12: 301-306
    CrossrefPubMedGoogle Scholar
  • 21 Ichinose A, Davie EW. Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 1988; 85: 5829-5833
    CrossrefPubMedGoogle Scholar
  • 22 Takahashi N, Takahashi Y, Putnam FW. Primary structure of blood coagulation factor XIII (fibrinoligase, transglutaminase) from human placenta. Proc Natl Acad Sci USA 1986; 83: 8019-8023
    CrossrefPubMedGoogle Scholar
  • 23 Emmerich J, Chadeuf G, Alhenc-Gelas M, Gouault-Heilman M, Toulon P, Fiessinger JN, Aiach M. Molecular basis of antithrombin type I deficiency: The first large in-frame deletion and two novel mutations in exon 6. Thromb Haemost 1994; 72: 534-539
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Chun K, MacKay N, Petrova-Benedict R, Robinson BH. Mutations in the X-linked Ela subunit of pyruvate dehydrogenase leading to deficiency of the pyruvate dehydrogenase complex. Hum Mol Genet 1993; 2: 449-454
    CrossrefPubMedGoogle Scholar
  • 25 Efstratiadis A, Posakony JW, Maniatis T, Lawn R, O’Connell C, Spritz RA, De Riel JL, Forget BG, Weissman SM, Slightom JL, Blechl AE, Smithies O, Baralle FE, Shoulders CC, Proudfoot NJ. The structure and evolution of the human β-globin gene family. Cell 1980; 21: 653-668
    CrossrefPubMedGoogle Scholar
  • 26 Britten AFH. Congenital deficiency of factor XIII (fibrin-stabilizing factor). Am J Med 1967; 43: 751-761
    CrossrefPubMedGoogle Scholar
  • 27 Duckert F. Documentation of the plasma factor XIII deficiency in man. Ann New York Acad Sci 1972; 202: 190-199
    CrossrefPubMedGoogle Scholar
  • 28 Yee VC, Pedersen LC, Le-Trong I, Bishop PD, Stenkamp RE, Teller DC. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 1994; 91: 7296-7300
    CrossrefPubMedGoogle Scholar
  • 29 Woodcock DM, Crowther PJ, Jefferson S, Diver WP. Methylation at dinucleotides other than CpG: implication for human maintenance methylation. Gene 1988; 74: 151-152
    CrossrefPubMedGoogle Scholar